Similar articles for PMID: 28490468

Year	Number of Results
2004	1
2005	1
2006	2
2007	1
2008	3
2009	3
2010	3
2011	2
2012	3
2013	6
2014	5
2015	13
2016	18
2017	21
2018	6
2024	0

1

Is Tau Imaging More Than Just Upside-Down ¹⁸F-FDG Imaging?

van Eimeren T, Bischof GN, Drzezga A. van Eimeren T, et al. J Nucl Med. 2017 Sep;58(9):1357-1359. doi: 10.2967/jnumed.117.190082. Epub 2017 May 10. J Nucl Med. 2017. PMID: 28490468 Free article. No abstract available.

2

Time for tau.

Jagust W. Jagust W. Brain. 2014 Jun;137(Pt 6):1570-1. doi: 10.1093/brain/awu093. Epub 2014 Apr 15. Brain. 2014. PMID: 24736306 Review. No abstract available.

3

Tau Imaging in Alzheimer's Disease Diagnosis and Clinical Trials.

Brosch JR, Farlow MR, Risacher SL, Apostolova LG. Brosch JR, et al. Neurotherapeutics. 2017 Jan;14(1):62-68. doi: 10.1007/s13311-016-0490-y. Neurotherapeutics. 2017. PMID: 27873182 Free PMC article. Review.

4

Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study.

Chiaravalloti A, Barbagallo G, Ricci M, Martorana A, Ursini F, Sannino P, Karalis G, Schillaci O. Chiaravalloti A, et al. Brain Res. 2018 Jan 1;1678:116-122. doi: 10.1016/j.brainres.2017.10.016. Epub 2017 Oct 21. Brain Res. 2018. PMID: 29066367

5

F-18 FDG and F-18 Tau PET in posterior cortical atrophy.

Tripathi M, Bansal A, Baghel V, Kumar P, Bal C. Tripathi M, et al. Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1779-1780. doi: 10.1007/s00259-017-3738-9. Epub 2017 Jun 6. Eur J Nucl Med Mol Imaging. 2017. PMID: 28584971 No abstract available.

6

Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808.

Chien DT, Szardenings AK, Bahri S, Walsh JC, Mu F, Xia C, Shankle WR, Lerner AJ, Su MY, Elizarov A, Kolb HC. Chien DT, et al. J Alzheimers Dis. 2014;38(1):171-84. doi: 10.3233/JAD-130098. J Alzheimers Dis. 2014. PMID: 23948934

7

Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer's disease.

Pascoal TA, Mathotaarachchi S, Shin M, Park AY, Mohades S, Benedet AL, Kang MS, Massarweh G, Soucy JP, Gauthier S, Rosa-Neto P; Alzheimer’s Disease Neuroimaging Initiative. Pascoal TA, et al. Eur J Nucl Med Mol Imaging. 2018 Jun;45(6):1021-1030. doi: 10.1007/s00259-018-3933-3. Epub 2018 Feb 2. Eur J Nucl Med Mol Imaging. 2018. PMID: 29396637 Free PMC article.

8

Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807.

Chien DT, Bahri S, Szardenings AK, Walsh JC, Mu F, Su MY, Shankle WR, Elizarov A, Kolb HC. Chien DT, et al. J Alzheimers Dis. 2013;34(2):457-68. doi: 10.3233/JAD-122059. J Alzheimers Dis. 2013. PMID: 23234879

9

Cerebrospinal fluid tau protein levels and 18F-fluorodeoxyglucose positron emission tomography in the differential diagnosis of Alzheimer's disease.

Yakushev I, Bartenstein P, Siessmeier T, Hiemke C, Scheurich A, Lotz J, Fellgiebel A, Müller MJ. Yakushev I, et al. Dement Geriatr Cogn Disord. 2010;30(3):245-53. doi: 10.1159/000320206. Epub 2010 Sep 15. Dement Geriatr Cogn Disord. 2010. PMID: 20847555

10

[Current and future prospects of nuclear medicine in dementia].

Ito K, Inui Y, Kizawa T, Kimura Y, Kato T. Ito K, et al. Rinsho Shinkeigaku. 2017 Sep 30;57(9):479-484. doi: 10.5692/clinicalneurol.cn-001016. Epub 2017 Aug 11. Rinsho Shinkeigaku. 2017. PMID: 28804110 Review. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

71 results

Results by year